3-Nitropropionic acid induces histological and behavioral alterations in adult zebrafish: role of antioxidants on behavioral dysfunction
Melissa Talita WiprichiD, Rafaela da Rosa Vasques, Amanda Bungi ZaluskiiD, Kanandra Taisa BertoncelloiD, Stefani AltenhofeniD, Darlan GussoiD, Gabriel Rodrigues, Adrieli SachettiD, Ângelo PiatoiD, Fábio Luiz Dal Moro MaitoiD, Mônica Ryff Moreira Roca ViannaiD, Carla Denise BonaniD
Abstract
Huntingtons disease (HD) is a neurodegenerative disease marked by progressive motor and non-motor symptoms such as neuropsychiatric disruption and cognitive dysfunction. It has been reported that some pathogenic mechanisms resulting in neuronal cell death in this disease involve neurodegeneration and oxidative stress. 3-Nitropropionic acid (3-NPA), a natural toxin that promotes the irreversible suppression of mitochondrial complex II, has been used to understand the HD pathogenesis. This neurotoxin mimics the biochemical, central neurodegeneration, peripheral and behavioral phenotype alterations observed in HD. Here we investigated 3-NPA (60 mg/kg) effects on histological and oxidative stress parameters on brain and muscular tissues. We also evaluated the effects of three antioxidant compounds on 3-NPA-induced behavioral phenotypes in adult zebrafish. For the evaluation of the antioxidant effects, adult zebrafish were submitted to a single acute intraperitoneal injection of vitamin C, creatine, or melatonin following 3-NPA chronic administration (60 mg/kg). 3-NPA treatment caused neurodegeneration, but did not alter the muscular tissue. 3-NPA neither change thiobarbituric acid reactive substances (TBARS) nor nonprotein thiol levels. Vitamin C and creatine treatments recovered the hypolocomotion induced by 3-NPA. Also, vitamin C and melatonin treatments improved the memory dysfunction caused by 3-NPA. Altogether, our findings showed that the 3-NPA induces neurodegeneration in adult zebrafish, and the vitamin C, creatine, and melatonin are beneficial in managing HD-like behavioral phenotypes. Thus, these antioxidants could be thought as complementary pharmacotherapies for the treatment of late-stage HD symptoms.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 3
- FWCI
- 3.27
- Field percentile
- top 7%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Nutritional Protection Against Antipsychotic-Related Brain Injury: Combined Omega-3 and Vitamin E Effects on the Cerebellum
Alake Tomiwa Goodness, Olakunle J. Onaolapo, Adejoke Y. Onaolapo·bioRxiv·Jan 7, 2026
- Behavioral and neurochemical effects of novel N-Benzyl-2-phenylethylamine derivatives in adult zebrafish
Konstantin A. Demin, Olga V. Kupriyanova, … Allan V. Kalueff·ACS Chemical NeurosciencePeer-reviewed·Jun 7, 2022
- Cerebral Dopamine Neurotrophic Factor regulates multiple neuronal subtypes and social behavior
Yu‐Chia Chen, Diego Baronio, … Pertti Panula·Journal of NeurosciencePeer-reviewed·Jul 6, 2020
- Inhibition of mitochondrial complex III causes selective dopaminergic neurotoxicity by redox stress in Caenorhabditis elegans
Javier Huayta, Aliyah S. Webster, … Joel N. Meyer·Redox BiologyPeer-reviewed·Aug 13, 2026
- 6-OHDA-induced dopaminergic neurodegeneration in C. elegans is promoted by the engulfment pathway and inhibited by the transthyretin-related protein TTR-33
Sarah-Lena Offenburger, Xue Yan Ho, … Anton Gartner·PLoS GeneticsPeer-reviewed·Jan 18, 2018
- NATO3 protects dopaminergic neurons in mouse in vivo and human in vitro Parkinson's disease models
Eva P. Valencia-Alarcón, Lou C. Duret, … Emi Nagoshi·bioRxiv·Oct 10, 2025